LAM IPM Wound Gel Efficacy Shines in Central America

LAM Pharmaceutical, a biomedical company focused on the development and commercialization of novel wound healing and transdermal drug delivery systems, announced that it was achieving excellent results from patient studies currently being conducted in Ecuador, Panama and Costa Rica. Salvador Ficciella, CEO of aQva Pharmaceuticals, LAM's distribution partner in the region, stated, "We are receiving exceptionally positive feedback on the use of LAM IPM Wound Gel in all three countries."

BioSpace (http://www.biospace.com/news_story.cfm?StoryID=19085120&full=1)